Jensen Quality Growth Equity Strategy Decided to Sell Its Stake in Zoetis (ZTS)

Core Insights - Jensen Investment Management's fourth-quarter investor letter for the "Jensen Quality Growth Equity Strategy" indicates that the strategy underperformed the S&P 500 Index in Q4 2025, returning -0.55% compared to the Index's 2.66% [1] - The underperformance was primarily attributed to the Industrials sector and the outperformance of low-quality stocks, highlighting a current market trend characterized by concentration in mega-cap technology [1] - The portfolio is strategically positioned to benefit from growth in AI and digital transformation while focusing on quality, cash generation, and durability for long-term shareholder returns [1] Company-Specific Insights - Zoetis Inc. (NYSE:ZTS), an animal health company, was highlighted in the investor letter, with its stock closing at $122.23 on March 05, 2026 [2] - Over the past month, Zoetis Inc. experienced a -4.07% return and a significant -28.26% decline over the past twelve months, with a market capitalization of approximately $53.866 billion [2] - The Quality Growth Investment Team liquidated positions in Zoetis Inc. along with Accenture (ACN) and Amphenol (APH) during the quarter [3]